Bill Gates Vaccine Feature photo
Pandemic Profiteers

Poor Nations Left Reeling After Bill Gates Advised Oxford to Ditch Open Source COVID Vaccine

Unable to secure a profit in immunizing poorer nations, Western multinationals, including Oxford’s private partner AstraZeneca, have prioritized those who can pay the most.